Form 4: Stoke Therapeutics Executive Jonathan Allan Reports Stock Transactions

Jonathan Allan, General Counsel & Corporate Secretary at Stoke Therapeutics, reports the acquisition of 33,927 shares of common stock and 33,927 restricted stock units on December 1, 2024.

Summary

• Jonathan Allan, General Counsel & Corporate Secretary of Stoke Therapeutics, filed a Form 4 detailing changes in his beneficial ownership of company stock.
• On December 1, 2024, Allan acquired 33,927 shares of common stock at $0 per share.
• He also acquired 33,927 restricted stock units (RSUs) which vest on December 1, 2024, and an additional 12,357 RSUs that will vest on December 1, 2025.
• The reported total includes 2,313 shares acquired through the company's Employee Stock Purchase Plan.
• Following these transactions, Allan directly owns 38,838 shares of common stock and 12,357 RSUs.

Sentiment

Score: 6

Explanation: The document is a routine filing of stock transactions by an executive. It is neither particularly positive nor negative, but indicates standard compensation practices.

Positives

• The acquisition of shares and RSUs by a key executive could be seen as a positive sign of confidence in the company's future.

Future Outlook

The document does not contain any forward-looking statements or guidance.

Industry Context

This is a standard SEC Form 4 filing, which is a routine disclosure for company insiders. It does not indicate any specific industry trends or competitive actions.

Comparison to Industry Standards

• Form 4 filings are a standard practice for publicly traded companies, and the transactions reported are typical for executive compensation and employee stock purchase plans.
• Similar filings are made by executives at comparable biotech companies such as Alnylam Pharmaceuticals and Biogen, when they receive stock options or RSUs.

Stakeholder Impact

• The transactions have a minor positive impact on shareholders as they indicate executive confidence in the company.

Key Dates

Keywords

Form 4, Stoke Therapeutics, Jonathan Allan, Stock Acquisition, Restricted Stock Units, RSU, Beneficial Ownership, Employee Stock Purchase Plan